Current Edition

Formulation of Drug Product for Paediatric Population – Challenges

One of the main specificities of the paediatric population is that this is a heterogeneous population. Potential paediatric patients are neonates, newborns, infants and toddlers, and adolescents. Therefore, paediatrics formulations must allow administration of an accurate and defined dose to patients of widely varying weight and age. Isabelle Decorte of Synerlab Développement touches upon the importance of designing an adequate drug product for the paediatric population.